VOR
Vor Biopharma Inc.
$20.31
+0.21 (+1.04%)
At close · Jul 8
Market Cap
$1.07B
Shares
54,185,877
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$20.31
Open$19.80
Day$19.05–20.36
52W$6.50–65.80
Avg vol 30d1.4M
Short int6.0M · 11.0% float · 7.1d
Short vol32%
DataFeb 2021–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+21%
above
Price vs 50-day avg
+32%
above
RSI (14)
73
overbought
MACD trend
Positive
52-week position
23%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+53%
trailing
6-month return
+51%
trailing
YTD return
+55%
this year
Relative strength
+43%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $15 › 200d $17 — 200d above 50d
Institutional flow
Accumulating
+43% holders QoQ · +35 funds added
Insider flow
Distributing
Net -$24.7M over 90 days · 100% sells
Short interest
Rising
10.98% of float · ▲ +23.5% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
80 holders — near 1-yr high, broad support
Squeeze score
79
high risk · 0–100
Fundamentals
EPS growth
−107%
Y/Y
Free cash flow
$-143.7M
Balance sheet
$396.5M
net cash
Quant / Vol
risk profile
Volatility
117%
annualized · 1-yr
Max drawdown
−87%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+21%
Bullish
Price vs 50-day avg
+32%
Bullish
RSI (14)
73
Bearish
MACD trend
Positive
Bullish
52-week position
23%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $15 › 200d $17 — 200d above 50d
Institutional flow
Accumulating
+43% holders QoQ · +35 funds added
Insider flow
Distributing
Net -$24.7M over 90 days · 100% sells
Short interest
Rising
10.98% of float · ▲ +23.5% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
80 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $7
Now $20 · 23%
52-wk high $66
vs 200-day avg +21%
vs 50-day avg +32%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VOR
this stock
Vor Biopharma Inc.
|
$1.07B | +55.3% | — | — | 11.0% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VOR | +10.3% | +52.8% | +50.6% | +10.3% | +55.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +10.5% | +52.0% | +43.1% | +10.5% | +46.0% |